Another one is left ventricular hypertrophy [41]; the analysis of the course of left ventricular mass index is also included as a secondary endpoint because the reducing the activation of the renin-angiotensin-aldosterone-system by RAS revascularisation should lead to a regression of left ventricular hypertrophy [41]. The gene discussed is REN; the disease is left ventricular hypertrophy.